Login

Blueprint Medicines Corp 4 SEC Filings

Filed On Filing
21 Jul 2025 Form 4: Landsittel Michael, Chief Financial Officer

Received 21,353 shares as a grant or award · Returned 51,102 shares to the issuer · Disposed of 43,175 shares (Tender Offer) · 1 more

21 Jul 2025 Form 4: Dable Habib J, Director

Returned 3,902 shares to the issuer · Disposed of 8,742 shares (Tender Offer) · Disposed of 17,820 Stock Option (Right to Buy) (Disposition to Issuer)

21 Jul 2025 Form 4: Hurley Ariel, Principal Accounting Officer

Received 2,460 shares as a grant or award · Returned 16,146 shares to the issuer · Disposed of 3,378 shares (Tender Offer) · 1 more

21 Jul 2025 Form 4: Tsai John, Director

Returned 3,902 shares to the issuer · Disposed of 8,742 shares (Tender Offer) · Disposed of 17,820 Stock Option (Right to Buy) (Disposition to Issuer)

21 Jul 2025 Form 4: Coats Lonnel, Director

Returned 6,144 shares to the issuer · Disposed of 61,369 Stock Option (Right to Buy) (Disposition to Issuer)

21 Jul 2025 Form 4: Hewes L. Becker, Chief Medical Officer

Received 21,353 shares as a grant or award · Returned 50,165 shares to the issuer · Disposed of 1,607 shares (Tender Offer) · 1 more

21 Jul 2025 Form 4: Seely Lynn, Director

Returned 3,902 shares to the issuer · Disposed of 13,254 shares (Tender Offer) · Disposed of 80,181 Stock Option (Right to Buy) (Disposition to Issuer)

21 Jul 2025 Form 4: Carter Percy H., Chief Scientific Officer

Received 21,353 shares as a grant or award · Returned 56,614 shares to the issuer · Disposed of 17,894 shares (Tender Offer) · 1 more

21 Jul 2025 Form 4: Rossi Christina, Chief Operating Officer

Received 39,456 shares as a grant or award · Returned 82,374 shares to the issuer · Disposed of 20,628 shares (Tender Offer) · 1 more

21 Jul 2025 Form 4: Haviland Kate, Director

Received 129,210 shares as a grant or award · Returned 224,410 shares to the issuer · Disposed of 70,729 shares (Tender Offer) · 1 more

21 Jul 2025 Form 4: Borisy Alexis, Director

Returned 3,902 shares to the issuer · Disposed of 74,160 shares (Tender Offer) · Disposed of 36,545 Stock Option (Right to Buy) (Disposition to Issuer)

21 Jul 2025 Form 4: Goldberg Mark Alan, Director

Returned 3,902 shares to the issuer · Disposed of 18,254 shares (Tender Offer) · Disposed of 47,454 Stock Option (Right to Buy) (Disposition to Issuer)

21 Jul 2025 Form 4: Namouni Fouad, PRESIDENT, R & D

Received 39,456 shares as a grant or award · Returned 83,281 shares to the issuer · Disposed of 31,956 shares (Tender Offer) · 1 more

21 Jul 2025 Form 4: Beckman Daniella, Director

Returned 3,902 shares to the issuer · Disposed of 10,842 shares (Tender Offer) · Disposed of 22,170 Stock Option (Right to Buy) (Disposition to Issuer)

21 Jul 2025 Form 4: McCain Tracey L, EVP & Chief Legal Officer

Received 21,353 shares as a grant or award · Returned 51,103 shares to the issuer · Disposed of 37,092 shares (Tender Offer) · 1 more

21 Jul 2025 Form 4: Durso-Bumpus Debra, Chief People Officer

Received 21,353 shares as a grant or award · Returned 51,103 shares to the issuer · Disposed of 19,856 shares (Tender Offer) · 1 more

21 Jul 2025 Form 4: Lee Philina, Chief Commercial Officer

Received 21,353 shares as a grant or award · Returned 50,165 shares to the issuer · Disposed of 13,184 shares (Tender Offer) · 1 more

21 Jul 2025 Form 4: Albers Jeffrey W., Director

Returned 5,777 shares to the issuer · Disposed of 144,755 shares (Tender Offer) · Disposed of 567,870 Stock Option (Right to Buy) (Disposition to Issuer)

08 Jul 2025 Form 4: Rossi Christina, CHIEF OPERATING OFFICER

Sold 1,172 shares ($150K)

08 Jul 2025 Form 4: Carter Percy H., CHIEF SCIENTIFIC OFFICER

Sold 1,051 shares ($135K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support